Log in to save to my catalogue

AB0036 Comparison of Tuberculin Skin Test and T-Spot.TB Test in Patients with Receiving Corticostero...

AB0036 Comparison of Tuberculin Skin Test and T-Spot.TB Test in Patients with Receiving Corticostero...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901803647

AB0036 Comparison of Tuberculin Skin Test and T-Spot.TB Test in Patients with Receiving Corticosteroid or Immunosuppressive Treatments

About this item

Full title

AB0036 Comparison of Tuberculin Skin Test and T-Spot.TB Test in Patients with Receiving Corticosteroid or Immunosuppressive Treatments

Publisher

Kidlington: Elsevier Limited

Journal title

Annals of the rheumatic diseases, 2015-06, Vol.74 (Suppl 2), p.902

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Limited

More information

Scope and Contents

Contents

BackgroundCytotoxic or anti-TNF therapies increase risk of reactivation of latent tuberculosis infection (LTBI). Therefore screening for latent tuberculosis is mandatory before initiating therapy. On the other hand, these patients who are candidate for cytotoxic or anti-TNF therapies are already on corticosteroid or immunosuppressive treatments. Th...

Alternative Titles

Full title

AB0036 Comparison of Tuberculin Skin Test and T-Spot.TB Test in Patients with Receiving Corticosteroid or Immunosuppressive Treatments

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1901803647

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1901803647

Other Identifiers

ISSN

0003-4967

E-ISSN

1468-2060

DOI

10.1136/annrheumdis-2015-eular.4782

How to access this item